Guangdong Hybribio Biotech Co.,Ltd. 300639.SZ
300639.SZ
Guangdong Hybribio Biotech Co.,Ltd. 301060.SZ
Shanghai Labway Clinical Laboratory Co., Ltd. 002022.SZ
Shanghai Kehua Bio-Engineering Co.,Ltd 600568.SS
Zhongzhu Healthcare Holding Co.,Ltd 300396.SZ
Dirui Industrial Co.,Ltd. 300439.SZ
Medicalsystem Biotechnology Co., Ltd. 300110.SZ
Huaren Pharmaceutical Co., Ltd. 688468.SS
Chemclin Diagnostics Co., Ltd. 605199.SS
Hainan Huluwa Pharmaceutical Group Co., Ltd. 300753.SZ
Jiangsu Apon Medical Technology Co., Ltd.
Guangdong Hybribio Biotech Co.,Ltd. 301060.SZ
Shanghai Labway Clinical Laboratory Co., Ltd. 002022.SZ
Shanghai Kehua Bio-Engineering Co.,Ltd 600568.SS
Zhongzhu Healthcare Holding Co.,Ltd 300396.SZ
Dirui Industrial Co.,Ltd. 300439.SZ
Medicalsystem Biotechnology Co., Ltd. 300110.SZ
Huaren Pharmaceutical Co., Ltd. 688468.SS
Chemclin Diagnostics Co., Ltd. 605199.SS
Hainan Huluwa Pharmaceutical Group Co., Ltd. 300753.SZ
Jiangsu Apon Medical Technology Co., Ltd.
Performance
| Periode | 300639.SZ | 301060.SZ | 002022.SZ | 600568.SS | 300396.SZ | 300439.SZ | 300110.SZ | 688468.SS | 605199.SS | 300753.SZ |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 10.69 % | 5.61 % | 21.20 % | 44.19 % | 0.45 % | -6.32 % | 10.44 % | 10.74 % | -39.83 % | 40.39 % |
| YTD | -3.12 % | 3.95 % | 6.43 % | 40.91 % | -14.28 % | 2.17 % | -4.93 % | 14.22 % | -43.65 % | 70.88 % |
| 1Y | -9.55 % | -16.49 % | 4.03 % | 57.63 % | -18.77 % | -7.08 % | -7.61 % | 13.37 % | -30.49 % | 102.31 % |
| 3Y | -57.62 % | -61.71 % | -51.68 % | 2.76 % | -40.99 % | -17.50 % | -20.39 % | -40.44 % | -40.23 % | 124.18 % |
| 5Y | -69.08 % | -49.53 % | -68.00 % | 9.41 % | -52.00 % | -49.98 % | -45.33 % | -69.41 % | -68.93 % | 14.00 % |
| 10Y | 42.60 % | -49.53 % | -75.48 % | -74.73 % | -45.59 % | -72.77 % | -47.10 % | -69.41 % | 19.95 % | 110.49 % |
| From the beginning | 42.60 % | -49.53 % | 290.98 % | -34.89 % | 41.06 % | -21.44 % | -14.14 % | -69.41 % | 19.95 % | 110.49 % |